DiscGenics Announces Positive Two-Year Clinical Data from U.S....
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SALT LAKE CITY, Jan. 25, 2023 /PRNewswire-AsiaNet/ -- -- Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD.Disc...
Authors: LATEST ASIANET NEWS RELEASES